Raloxifene enhances material- level mechanical properties of femoral cortical and trabecular bone

被引:39
作者
Allen, Matthew R. [1 ]
Hogan, Harry A.
Hobbs, Wesley A.
Koivuniemi, Andrew S.
Koivuniemi, Mark C.
Burr, David B.
机构
[1] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Dept Orthopaed Surg, Indianapolis, IN 46202 USA
[2] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA
[3] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA
关键词
D O I
10.1210/en.2007-0275
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have previously documented that raloxifene enhances the mechanical properties of dog vertebrae independent of changes in bone mass, suggesting a positive effect of raloxifene on material-level mechanical properties. The goal of this study was to determine the separate effects of raloxifene on the material- level mechanical properties of trabecular and cortical bone from the femur of beagle dogs. Skeletally mature female beagles (n = 12 per group) were treated daily for 1 yr with oral doses of vehicle or raloxifene (0.50 mg/ kg center dot d). Trabecular bone mechanical properties were measured at the femoral neck using reduced platen compression, a method that allows the trabecular bone to be tested without coring specimens. Cortical bone properties were assessed on prismatic beam specimens machined from the femoral diaphysis using both monotonic and dynamic (cyclic relaxation) fourpoint bending tests. Trabecular bone from raloxifene- treated animals had significantly higher ultimate stress ( + 130%), modulus (+ 89%), and toughness (+ 152%) compared with vehicletreated animals. Cortical bone from raloxifene- treated animals had significantly greater toughness (+ 62%) compared with vehicle, primarily as a function of increased postyield displacement (+ 100%). There was no significant difference between groups in the percentage of stiffness loss during cortical bone cyclic relaxation tests. These results are consistent with previous data from the vertebrae of these same animals, showing raloxifene has positive effects on biomechanical properties independent of changes in bone volume/density. This may help explain how raloxifene reduces osteoporotic fractures despite modest changes in bone mass.
引用
收藏
页码:3908 / 3913
页数:6
相关论文
共 27 条
  • [1] Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib
    Allen, M. R.
    Follet, H.
    Khurana, M.
    Sato, M.
    Burr, D. B.
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2006, 79 (04) : 255 - 261
  • [2] Raloxifene enhances vertebral mechanical properties independent of bone density
    Allen, Matthew R.
    Iwata, Ken
    Sato, Masahiko
    Burr, David B.
    [J]. BONE, 2006, 39 (05) : 1130 - 1135
  • [3] Mechanical properties of adult vertebral cancellous bone: Correlation with collagen intermolecular cross-links
    Banse, X
    Sims, TJ
    Bailey, AJ
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (09) : 1621 - 1628
  • [4] Burr D.B., 2003, PRIMER METABOLIC BON, P58
  • [5] The contribution of the organic matrix to bone's material properties
    Burr, DB
    [J]. BONE, 2002, 31 (01) : 8 - 11
  • [6] ULTIMATE PROPERTIES OF BONE TISSUE - EFFECTS OF YIELDING
    BURSTEIN, AH
    FRANKEL, VH
    CURREY, JD
    REILLY, DT
    [J]. JOURNAL OF BIOMECHANICS, 1972, 5 (01) : 35 - &
  • [7] Bone strength: What are we trying to measure?
    Currey, JD
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2001, 68 (04) : 205 - 210
  • [8] Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties
    Day, JS
    Ding, M
    Bednarz, P
    van der Linden, JC
    Mashiba, T
    Hirano, T
    Johnston, CC
    Burr, DB
    Hvid, I
    Sumner, DR
    Weinans, H
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 2004, 22 (03) : 465 - 471
  • [9] Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial
    Delmas, PD
    Genant, HK
    Crans, GG
    Stock, JL
    Wong, M
    Siris, E
    Adachi, JD
    [J]. BONE, 2003, 33 (04) : 522 - 532
  • [10] Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial
    Delmas, PD
    Ensrud, KE
    Adachi, JD
    Harper, KD
    Sarkar, S
    Gennari, C
    Reginster, JY
    Pols, HAP
    Recker, RR
    Harris, ST
    Wu, WT
    Genant, HK
    Black, DM
    Eastell, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) : 3609 - 3617